Skip to main content
. Author manuscript; available in PMC: 2018 Aug 10.
Published in final edited form as: Diabetologia. 2017 Aug 23;60(11):2200–2209. doi: 10.1007/s00125-017-4402-4

Table 3.

Crude and standardised incident event and mortality rates among type 2 diabetes mellitus cases, Västerbotten Intervention Programme 1992-2013.

Deaths CVD events Renal Disease Retinopathy
n MR StdMR n IR StdIR n IR StdIR n IR StdIR
Confirmed screen-detected cases 73 8.2 4.2 128 15.5 8.7 39 4.4 3.3 70 8.1 6.3
Unconfirmed screen-positive cases 139 10.4 5.9 141 11.0 5.8 23 1.7 0.9 9 0.7 0.4
Incident clinically detected cases 1330 21.4 15.5 1,704 30.5 21.9 649 10.8 9.3 757 12.7 12.7
     Screening-participants 515 18.8 11.5 680 27.1 19.8 258 9.6 8.6 279 10.5 9.7
         Previous diabetic OGTT > 1 year pre-detection 93 17.0 9.4 114 22.9 13.7 41 7.7 5.0 70 13.3 9.9
         Previous non-diabetic hyperglycaemia 194 16.4 12.0 267 24.5 21.0 100 8.7 10.5 103 9.0 10.3
         Previous normoglycaemia 206 22.0 12.5 275 32.3 20.4 102 11.2 7.9 91 10.0 8.8
     Screening non-participants 815 23.4 18.4 1,024 33.3 25.5 391 11.6 10.2 478 14.6 14.2

IR and MR reported per 1,000 person-years. Age and sex standardised MR and IR are calculated with the total study population as reference.

Rates do not include events that coincide with date of diabetes detection.

CVD, renal and retinal events detected in Hospital Outpatient and Inpatient Discharge Registers, and the Cause of Death Register.

Unconfirmed screen-positive cases had only a diabetic screening result, whereas confirmed screen-detected cases had a diabetic screening result and a medical or prescription record of diabetes within one year. Clinically detected diabetes cases were identified in five sources of medical and prescription records, unrelated to screening.

CVD: Cardiovascular disease, IR: Incidence rate, MR: Mortality rate, OGTT: Oral glucose tolerance test, StdIR; Standardised Incidence Rate, StdMR: Standardised Mortality Rate.